420 related articles for article (PubMed ID: 9336193)
1. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
2. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
3. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence.
Suárez T; Nir S; Goñi FM; Saéz-Cirión A; Nieva JL
FEBS Lett; 2000 Jul; 477(1-2):145-9. PubMed ID: 10899326
[TBL] [Abstract][Full Text] [Related]
4. [Fusion of negatively-charged liposomes under the effect of peptides from the N-terminal fragment of the HIV-1 transmembrane protein].
Terletskaia IaT; Trikash IO; Serdiuk ES; Andreev SM
Biokhimiia; 1995 Oct; 60(10):1711-9. PubMed ID: 8555367
[TBL] [Abstract][Full Text] [Related]
5. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
Korazim O; Sackett K; Shai Y
J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage.
Nieva JL; Nir S; Muga A; Goñi FM; Wilschut J
Biochemistry; 1994 Mar; 33(11):3201-9. PubMed ID: 8136355
[TBL] [Abstract][Full Text] [Related]
7. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
8. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
[TBL] [Abstract][Full Text] [Related]
9. Conformational transitions of membrane-bound HIV-1 fusion peptide.
Sáez-Cirión A; Nieva JL
Biochim Biophys Acta; 2002 Aug; 1564(1):57-65. PubMed ID: 12100996
[TBL] [Abstract][Full Text] [Related]
10. The hydrophobic internal region of bovine prion protein shares structural and functional properties with HIV type 1 fusion peptide.
Sáez-Cirión A; Nieva JL; Gallaher WR
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):969-78. PubMed ID: 14678604
[TBL] [Abstract][Full Text] [Related]
11. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
[TBL] [Abstract][Full Text] [Related]
12. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
Pereira FB; Goñi FM; Nieva JL
FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
[TBL] [Abstract][Full Text] [Related]
13. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
[TBL] [Abstract][Full Text] [Related]
14. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
Kanyalkar M; Srivastava S; Saran A; Coutinho E
J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
[TBL] [Abstract][Full Text] [Related]
15. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
Fujii G; Horvath S; Woodward S; Eiserling F; Eisenberg D
Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764
[TBL] [Abstract][Full Text] [Related]
16. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
Slepushkin VA; Andreev SM; Sidorova MV; Melikyan GB; Grigoriev VB; Chumakov VM; Grinfeldt AE; Manukyan RA; Karamov EV
AIDS Res Hum Retroviruses; 1992 Jan; 8(1):9-18. PubMed ID: 1736943
[TBL] [Abstract][Full Text] [Related]
17. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
18. Membrane-induced conformational change during the activation of HIV-1 gp41.
Kliger Y; Peisajovich SG; Blumenthal R; Shai Y
J Mol Biol; 2000 Aug; 301(4):905-14. PubMed ID: 10966795
[TBL] [Abstract][Full Text] [Related]
19. Determinants of membrane activity from mutational analysis of the HIV fusion peptide.
Torres O; Bong D
Biochemistry; 2011 Jun; 50(23):5195-207. PubMed ID: 21561063
[TBL] [Abstract][Full Text] [Related]
20. Membrane fusion induced by the HIV type 1 fusion peptide: modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds.
Pereira FB; Goñi FM; Nieva JL
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1203-11. PubMed ID: 9310287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
